Clinical Trial Update: Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery [Phase 2]

View source ↗

Summary

Phase 2 trial update on ipilimumab induction in melanoma patients with brain metastases undergoing stereotactic radiosurgery; study terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Metastatic Melanoma, Brain Metastases | Phase 2 | Status: TERMINATED | Results posted: 2018-01-19